Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think people are splitting hairs on the '584 issue. The reality is it appears

<I'll add that unless something significant has changed in the 584 as relates to the weak application towards ARM's chips, they will not be sued by TPL again. >

A couple of points with respect to the above.

ARM was never sued by TPL/PTSC. I doubt they would ever take on ARM directly.

It is my belief that claim 29 has been strengthened.

It would help to know whether the 584 stipulation can be overturned, how that can be accomplished, and whether it it worth the effort. I assumed that the USPTO has the final say on claim language, and thus all the prior court determinations based on erroneous interpetations could be challenged. Perhaps an erroneous assumption on my part?

Sorry if the board has already beaten this subject to death, just catching up on the reading this am. Opty

Share
New Message
Please login to post a reply